Full View

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

I Pacchiarotti, DJ Bond… - American Journal of …, 2013 - Am Psychiatric Assoc
Objective The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …
被引用次数：769 相关文章

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

I Pacchiarotti, DJ Bond, RJ Baldessarini… - THE AMERICAN …, 2013 - iris.uniroma1.it
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use
in bipolar disorders IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

I Pacchiarotti, DJ Bond… - American …, 2013 - mayoclinic.pure.elsevier.com
Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

I Pacchiarotti, DJ Bond, RJ Baldessarini… - The American Journal …, 2013 - europepmc.org
Objective The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

I Pacchiarotti, DJ Bond, RJ Baldessarini… - American Journal of …, 2013 - experts.umn.edu
Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

I Pacchiarotti, DJ Bond, RJ Baldessarini… - American Journal of …, 2013 - dash.harvard.edu
Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

I Pacchiarotti, DJ Bond… - American Journal …, 2013 - snucm.elsevierpure.com
Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …

[引用][C] The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

I Pacchiarotti, DJ Bond, RJ Baldessarini… - American Journal of …, 2013 - cir.nii.ac.jp

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

I Pacchiarotti, DJ Bond… - American Journal of …, 2013 - pure.johnshopkins.edu
Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

I Pacchiarotti, DJ Bond, RJ Baldessarini… - American Journal of …, 2013 - eprints.ncl.ac.uk
Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …